It ought to be an interesting earnings call next week for CVS Health (ticker: CVS).
Former Aetna CEO Mark Bertolini resigned from CVS Health’s Board of Directors last night. Bertolini told the Wall Street Journal that the CVS Health / Aetna post-deal integration is far from over – a statement that contradicts CVS Health CEO Larry Merlo’s public statements. CVS Health acquired Aetna for approximately $78 billion (including the assumption of Aetna’s debt), in November 2018.
Click HERE to read our Revenue Cycle Management (“RCM”), healthcare IT report including 26 RCM software providers.